ä At present, individual techniques, including intraoperative acute normovolemic hemodilution, use of tranexamic acid, use of intrathecal morphine, proper positioning, and modification of operative techniques, seem most promising for reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery.
Blood loss is a major issue in spine surgery. With increased awareness of the potential hazards of allogeneic blood transfusion, reducing blood loss during major spine procedures becomes more important. Achievement of this goal requires a concerted effort from spine surgeons and anesthesiologists alike. While a prior review of techniques to decrease blood loss during major spine surgery has been published 1 , newer techniques and concepts continue to evolve rapidly in this field. The present article provides a comprehensive review of the most recent techniques and concepts in this area, which we have divided into those applicable in the preoperative, intraoperative, and postoperative periods (Table I) .
Preoperative Period Optimal Management of Concurrent Medications That May Affect Intraoperative Bleeding
Antiplatelet medications such as aspirin and clopidogrel are commonly prescribed for patients with cardiovascular or cerebrovascular disease. Either continuation or discontinuation of these medications preoperatively may be associated with risks. In a meta-analysis of 500 patients receiving aspirin on a chronic basis, Burger et al. 2 showed that withdrawal from low-dose aspirin was the preceding event in 10.2% of patients who developed acute myocardial infarction, stroke, or peripheral arterial occlusion, or who died of cardiac complications, during non-cardiac surgery. However, continuation of aspirin use increased the rate of intraoperative bleeding complications by a factor of 1.5, although without a concomitant increase in perioperative morbidity or mortality except after intracranial surgery and transurethral prostatectomy. Hence, Burger et al. recommended discontinuing aspirin use only if the risk of bleeding outweighed the cardiovascular risks of aspirin withdrawal. Chassot et al. reviewed the results of perioperative antiplatelet therapy in patients at risk for myocardial infarction and recommended an algorithm approach for making the Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. None of the authors, or their institution(s), have had any financial relationship, in the thirty-six months prior to submission of this work, with any entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. Also, no author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by the authors of this work are available with the online version of this article at jbjs.org.
. The algorithm took into account the indication for treatment as well as the type of operation. Discontinuation of aspirin use seven days before intracranial surgery was recommended by Chassot et al. However, Chassot et al. recommended performing the spine procedure without interruption of aspirin use when a patient had had a recent myocardial infarction (less than six weeks before the operation) or insertion of a drug-eluting stent less than twelve months previously. Spine surgery was not specifically addressed in the review by Burger et al.
The effect of low-dose aspirin on bleeding during spine surgery has never been studied well. In a recent survey in which neurosurgeons at 142 neurosurgical facilities were successfully interviewed 4 , two-thirds (ninety-four) of the respondents believed aspirin to be a risk factor for hemorrhagic complications associated with spine procedures, and more than half of the neurosurgeons interviewed reported having personal experience of such problems during spine operations. Moreover, a subgroup of specialists who performed more than 600 spine operations per year thought that use of low-dose aspirin should be discontinued seven days before the operation. In the absence of more solid evidence, these opinions are not unreasonable.
Additional studies are needed to provide more evidence on this subject.
Continuation of clopidogrel use by patients undergoing non-cardiac surgery was shown to be associated with substantial ;bleeding 3 . Although no increase in morbidity and mortality (except for patients treated with intracranial surgery) was found, surgical bleeding and transfusion rates were increased by 50%.
Many orthopaedic patients may be taking nonselective cyclooxygenase (COX) inhibitors (nonsteroidal anti-inflammatory drugs [NSAIDs]) preoperatively for their anti-inflammatory and analgesic effects. These drugs have antiplatelet effects similar to those of aspirin. However, because they are reversible COX inhibitors, their antiplatelet effects disappear usually over twentyfour hours after discontinuation 5 . Recently, the platelet function analyzer PFA-100 was found to be useful in monitoring the degree of platelet inhibition in these patients preoperatively 6 .
Autologous Predonation
Autologous blood predonation is an established technique that has been reported to be safe and effective, decreasing the need for allogeneic blood transfusion in lumbar spine fusion and scoliosis surgery 7, 8 . However, in a retrospective study of 676 9 . Moreover, there was no significant difference in allogeneic blood transfusion rates between the two groups.
A critical issue in the success of a predonation program is the patient's rate of erythropoiesis. Use of erythropoietin in conjunction with an iron sulfate supplement can increase the number of autologous blood units that the patient can donate 10 .
Intraoperative Period
Acute Normovolemic Hemodilution Acute normovolemic hemodilution is widely used in spine surgery and has had good results in terms of decreasing the allogeneic blood transfusion requirements of patients treated with spine fusion 11, 12 as well as in those treated with scoliosis surgery 13, 14 . Epstein et al. 15 reported that allogeneic blood transfusion was avoided by fifty-two of sixty-eight patients treated with acute normovolemic hemodilution during lumbar spine fusion with instrumentation. The author of an earlier review article 16 concluded that acute normovolemic hemodilution was both safe and effective in decreasing the need for allogeneic blood transfusion, especially in patients undergoing multilevel lumbar laminectomies with or without fusions. One additional benefit is that acute hemodilution of up to 30% may induce a mild hypercoagulable state 17, 18 , which may help to reduce intraoperative bleeding.
The volume of blood available for collection is determined by the individual patient's preoperative blood volume, hematocrit, and targeted hematocrit (estimated blood volume · [baseline hematocrit -targeted hematocrit]/average hematocrit) 8 . There may be some difficulty with combining this technique with autologous predonation.
Intraoperative Red-Blood-Cell Salvage The role of intraoperative red-blood-cell salvage in reducing the need for allogeneic blood transfusion remains controversial. It was reported to be effective in reducing allogeneic blood transfusion in spine laminectomies, fusions, or instrumentation in several retrospective studies [19] [20] [21] , a meta-analysis 22 , and a Cochrane review 23 . However, the quality of these studies varies. A recent retrospective study by Gause et al. 24 showed that the use of intraoperative red-blood-cell salvage in elective lumbar fusion with instrumentation not only did not decrease the need for blood transfusion, but was also associated with substantially greater blood loss. Although the authors could not explain the apparent paradox, they proposed that perhaps surgeons became less meticulous with hemostasis in the presence of blood salvage. Alternatively, the reinfused salvaged blood might have contained products that interfered with normal coagulation.
Cost is a frequent concern about the use of intraoperative blood salvage. The cost of red-blood-cell salvage has been shown to exceed its benefits in patients undergoing correction for idiopathic scoliosis 13 . When red-blood-cell salvage was compared with acute normovolemic hemodilution, the latter was found to be more cost-effective 25 . It has been estimated that red-blood-cell salvage is cost-effective only if at least two blood units are recovered 26 .
Red-blood-cell salvage is contraindicated for surgical procedures involving a tumor, infection, or application of some topical agents.
Use of Hemostatic Drugs

Antifibrinolytics
Recent meta-analyses supported the usefulness of antifibrinolytics. A meta-analysis in 2009 27 showed that aprotinin and tranexamic acid substantially reduced blood loss in pediatric scoliosis surgery, a finding that was in agreement with that of a Cochrane review in 2008 28 . Another meta-analysis in 2008 29 also showed tranexamic acid and epsilon-aminocaproic acid to be effective in reducing blood loss and transfusion requirements, with no substantial morbidity or increased rate of thromboembolic events, in patients undergoing spine surgery.
Aprotinin
Aprotinin is a potent serine protease inhibitor extracted from bovine lung tissues. It reduces fibrinolysis by inhibiting plasmin activity and has been found to reduce blood loss in cardiac surgery since 1987 30, 31 . Aprotinin decreased blood loss and blood transfused in patients undergoing major orthopaedic surgery that was expected to result in blood loss of >2000 mL 32 , but its usage in spine surgery showed conflicting results. Previous controlled studies demonstrated a reduction in blood loss and transfusion requirements in adult patients undergoing spine reconstruction surgery 33 and in children and adolescents undergoing spine surgery with fusions to correct deformity 34 . More recent studies also demonstrated promising results with regard to decreasing blood loss and the need for allogeneic blood transfusion in adults undergoing spine surgery to correct deformity and those undergoing surgery to address neuromuscular scoliosis 35, 36 . However, one randomized prospective study did not show any reduction in blood loss in adolescents undergoing surgery for idiopathic scoliosis 37 . Another study demonstrated a reduction in intraoperative and postoperative blood loss, but not in allogeneic blood transfusion, in patients treated with posterior spine fusion 38 . Notably, in recent years aprotinin was associated with concerns about increased risks of perioperative myocardial infarction, stroke, renal dysfunction 39 , and anaphylaxis. A recent large-scale study involving 2331 patients showed that using aprotinin in high-risk cardiac surgery was associated with higher rates of mortality from cardiogenic shock, right ventricular failure, congestive heart failure, or myocardial infarction 40 . Similarly, aprotinin use in adults undergoing spine surgery to correct deformity may be associated with an increased risk of acute renal failure and deep venous thrombosis 41 . The U.S. Food and Drug Administration (FDA) suspended use, except for investigational use, of aprotinin in late 2007.
Tranexamic Acid
Tranexamic acid is a synthetic lysine analogue that inhibits the binding of lysine residues on fibrin to plasmin or plasminogen,
thus preventing fibrinolysis. It has well-established efficacy in reducing blood loss in knee and hip replacement surgery. In contrast, the efficacy of tranexamic acid in reducing blood loss in spine surgery has only recently been studied. Shapiro et al. 42 showed that tranexamic acid significantly reduced (p < 0.001) both intraoperative blood loss and allogeneic blood transfusion requirements in spine fusions for treatment of scoliosis in patients with Duchenne muscular dystrophy. Elwatidy et al. 43 found that the prophylactic use of high-dose tranexamic acid was an effective, safe, and inexpensive method for reducing blood loss during and after spine operations. Wong et al. 44 reported significantly reduced (p = 0.017) perioperative blood loss during elective posterior thoracic or lumbar spine fusion with instrumentation in adults. Grant et al. 45 showed that the efficacy of tranexamic acid is dose-dependent. The use of a higher dose (a 20-mg/kg loading dose followed by 10-mg/kg/hr intravenous infusion) for patients with idiopathic scoliosis resulted in a 50% reduction in transfusion requirements compared with those associated with a lower dose (10-mg/kg loading dose followed by a 1-mg/kg/hr intravenous infusion).
Epsilon-Aminocaproic Acid
Epsilon-aminocaproic acid is another lysine analogue with antifibrinolytic action. There are conflicting data regarding the efficacy of epsilon-aminocaproic acid in reducing blood loss during spine surgery. Florentino-Pineda et al. 46 found a decrease in blood loss and transfusion needs in patients undergoing surgery for idiopathic scoliosis. Recently, Thompson et al. further established the role of epsilon-aminocaproic acid in reducing blood loss and transfusion requirements in patient undergoing anterior or posterior spine fusions for idiopathic scoliosis 47 and neuromuscular scoliosis 47, 48 . However, other studies [49] [50] [51] did not show any benefit of epsilon-aminocaproic acid in major surgery, including orthopaedic procedures.
Recombinant Factor VIIa
Recombinant factor VIIa improves hemostasis by enhancing thrombin formation on activated platelets. It was approved by the U.S. FDA for use in hemophilic patients with bleeding. Off-label uses have been reported in operative settings such as trauma surgery [52] [53] [54] , neurosurgery 55, 56 , prostatic surgery 57 , cardiac surgery [58] [59] [60] [61] , and spine surgery 62 . Two recent studies showed promising results in terms of reducing blood loss and allogeneic blood transfusion during spine surgery. The first was a retrospective case series of adolescents with idiopathic scoliosis 63 , and the second was a prospective randomized controlled trial 64 . Although the authors of the randomized controlled trial claimed that ''no safety concerns were indicated for the use of rFVIIa in patients at all doses tested,'' the study may be underpowered to address such concerns. Moreover, there was one case of myocardial infarction and one case of ischemic stroke in the group that received recombinant factor VIIa in this study, findings that warrant further investigation.
A retrospective review showed that when 15 to 180 mg/kg of recombinant factor VIIa was administered to patients with bleeding due to a coagulopathy in medical and surgical settings, 80% (thirty-two of forty) had complete or partial cessation of the bleeding 65 . Another study showed that cessation of bleeding was not significantly different among doses of <70 mg/kg, 70 to 90 mg/kg, and >90 mg/kg 66 . Thus, the current recommended dose of recombinant factor VIIa is about 70 to 90 mg/kg.
We do not advocate the off-label use of any medication, including recombinant factor VIIa. In addition, there are two major concerns about the use of recombinant factor VIIa: thrombotic complications and its cost. The risk of thrombotic events with approved uses of recombinant factor VIIa is low 67 , but thrombotic stroke, myocardial infarction, deep vein thrombosis, and mortality have all been reported in association with offlabel use of the drug, including in patients undergoing spine surgery 64 . The cost of a single dose of 90 mg/kg in a 70-kg adult is over $5000.
Desmopressin
Desmopressin, also known as DDAVP, is a synthetic analogue of the antidiuretic hormone vasopressin. It increases the levels of factor VIII and von Willebrand factor and is indicated for use in von Willebrand disease, platelet disorders, or platelet dysfunction in patients with cirrhosis or renal failure 68 . Its use in spine surgery to decrease intraoperative blood loss has been reported, but a definite benefit has not yet been established. A controlled trial 69 showed desmopressin use to be associated with a decrease in blood loss and transfusion requirements in scoliosis surgery. However, a considerable number of other studies did not show a reduction of blood loss in patients undergoing surgery for idiopathic, congenital, or neuromuscular scoliosis [70] [71] [72] . The authors of one study reported that there was no evidence to support the routine use of desmopressin in orthopaedic surgery 50 .
Use of Intrathecal Morphine
A meta-analysis by Guay 73 showed that neuraxial blocks (epidural or spinal) in addition to general anesthesia or as the sole anesthetic technique decrease intraoperative and postoperative blood loss as well as the need for transfusion associated with different types of operative interventions, including spine fusion. The use of local anesthetics in neuraxial blocks causes hypotension, which is generally believed to cause the reduction in blood loss associated with neuraxial blocks. The use of localanesthetic-based neuraxial blocks in major spine surgery may be undesirable because of the associated hypotension, which may aggravate hemodynamic instability should major bleeding occur, as well as because of concerns about hypotension in a patient in a prone position. In addition, the use of local anesthetic neuraxial blocks may make neurological assessment more difficult postoperatively.
Unlike local anesthetics, neuraxial opioids such as intrathecal morphine do not interfere with neurological assessment and they cause less hypotension. Intrathecal morphine reduces blood loss in major spine surgery, in addition to providing satisfactory pain relief. In at least three prospective randomized trials, intrathecal morphine administered before operations substantially reduced intraoperative blood loss. Goodarzi 74 used 0.02 mg/kg of intrathecal morphine together with 50 mg of sufentanil and observed a 50% reduction in blood loss. Gall et al. 75 used 2 and 5 mg/kg of morphine and observed a 65% reduction in blood loss in the 5-mg/kg group. Eschertzhuber et al. 76 showed that intrathecal morphine (either 5 or 15 mg/kg, plus 1 mg/kg of sufentanil) reduced blood loss by 48%. Despite the consistent efficacy, the mechanism for this benefit remains elusive.
Use of Controlled Hypotension
Controlled hypotension has been used for decades in orthopaedic surgery to limit blood loss. Decreased blood extravasation and local wound blood flow with lower arterial blood pressure is the generally perceived benefit of this technique. However, since epidural venous plexus pressure 77 and intraosseous pressure 78 are more important determinants of blood loss in spine surgery in which bone decortications are involved, and both are independent of arterial blood pressure, the exact mechanism and value of this technique are still unknown.
The main concern with the use of controlled hypotension is its potential complications. The most worrisome is postoperative loss of vision, which is estimated to occur in 0.09% of patients (three of 3351 patients) undergoing spine surgery in the prone position 79 . A long operative time, a prone position with direct pressure to the eyes, massive blood loss, anemia, and hemodilution are risk factors for loss of vision after spine surgery. Hypotension is frequently observed in patients who have postoperative loss of vision, although a definite association remains to be established 80 . Induced hypotension must be used extremely cautiously in patients undergoing surgery in the prone position.
Low systolic blood pressure can also jeopardize perfusion to end organs, including the spinal cord. Studies have shown changes in the findings of evoked potential monitoring but no increase in the rate of neurological deficits with controlled hypotension 81 . Given the potential adverse effect of induced hypotension on organ perfusion, the safety of induced hypotension, particularly in combination with other techniques that may also affect tissue oxygen delivery such as hemodilution, requires proper evaluation.
Temperature Regulation
Hypothermia can lead to hemostatic impairment. Michelson et al. 82 found that the most important factor in the development of hemostatic impairment is cold-induced impairment of platelet function. Impaired enzyme activity in the coagulation cascade plays only a minor role.
Mild hypothermia can increase blood loss and allogeneic blood transfusion requirements during operative treatment. Schmied et al. compared patients who had been randomized to not receive active warming (mean core temperature, 35°C) and those who had been actively warmed (mean core temperature, 36.6°C) during hip arthroplasty and found a 30% increase in blood loss and a significant increase in blood transfusion requirements (p < 0.05) in the former group 83 . Similarly, Winkler et al. found a 26% increase in blood loss in patients undergoing hip arthroplasty with a core temperature of 36.1°C compared with those aggressively warmed and with a core temperature of 36.5°C 84 . The observation that such small differences in core temperature were of importance is substantiated by a recent meta-analysis 85 , which showed that a core temperature difference of <1°C was associated with an average increase in blood loss of 16% and an average increase in the risk of transfusion of 22% in all types of surgery, including hip arthroplasty, cardiac surgery, major abdominal surgery, and hysterectomy.
No evidence regarding the use of temperature regulation in spine surgery is available, to our knowledge. Moreover, a retrospective review by Guest et al. 86 showed that mild hypothermia was not associated with any increase in blood loss during spine surgery, although this was a small study involving only seventy patients. Additional studies are required to confirm and explain this apparent discrepancy between spine surgery and other surgical procedures.
Intraoperative Considerations
Patient Positioning
It is known that epidural veins are connected to the inferior vena cava by a valveless venous system. In the prone position, abdominal pressure increases and causes compression to the vena cava, which in turn increases pressure in the epidural venous circuit and increases intraoperative blood loss. In 1990, Böstman et al. 87 demonstrated a significant reduction (p < 0.001) in intraoperative blood loss during lumbar spine surgery in patients who had been placed on a frame in a supported kneeling position with the abdomen free compared with patients lying on conventional bolsters. The investigators postulated that this effect was brought about by a reduction in the inferior vena caval pressure. This postulation was confirmed by Lee et al. 77 . Those investigators studied differences in inferior vena caval pressure between patients positioned in the traditional prone position on a conventional pad and those positioned on a Relton-Hall frame with the abdomen free from compression. They found that vena caval pressure was significantly lower (p < 0.05) in the patients on the Relton-Hall frame. More recently, Park 88 found a correlation between reduction in intra-abdominal pressure and reduction in intraoperative blood loss in spine surgery. In their study, patients were randomly assigned to lie on a Wilson frame with narrow or wide pad support. The investigators found that both intra-abdominal pressure (p < 0.05) and intraoperative blood loss (p < 0.05) were significantly lower in the wide-pad-support group, in which the patient's abdomen was free from compression during surgery. Total intraoperative blood loss was also found to be highly correlated with the mean intra-abdominal pressure during surgery.
Operative Techniques
The skin over the back, particularly over the neck region, is well perfused. Blood oozing from the skin edge is common after a surgical incision. This oozing can be minimized by local skin infiltration of 1:500,000 epinephrine. Nutrient vessels to paraspinal muscles are in close proximity to the vertebrae. Subperiosteal dissection is essential to minimize damage to these vessels and hence to reduce intraoperative bleeding 89 . Taking the proper sequence of intraoperative steps can also help to reduce blood loss. Spine fusions frequently require decortication of the bone surfaces and lead to bone bleeding. Such bleeding can be minimized by performing this part of the procedure last, followed by the immediate creation of a tamponade of the wound with rapid watertight wound closure. Careful operative hemostasis can reduce intraoperative and postoperative blood loss. Soft-tissue bleeding can usually be stopped with thermal coagulation. Bone bleeding can be stopped with a small amount of bone wax. Epidural bleeding can usually be controlled with bipolar diathermy. If the venous pressure is low, applying hydrostatic pressure by just filling the wound with saline solution may help control epidural venous bleeding 90 .
Use of Topical Hemostatic Agents
Despite all of the above techniques, bleeding can still be difficult to control. Various topical hemostatic agents are available for use in these situations. They can be divided into two broad categories: passive and active. Passive agents act through contact activation and promotion of platelet aggregation. Active agents generate a fibrin clot following activation of the clotting cascade. Collagen-based, cellulose-based, and gelatin-based hemostatic products are examples of passive topical hemostatic agents. The basic mechanism of action is provision of a physical structure that promotes platelet aggregation, leading to clot formation and effective hemostasis 91 . Active agents have biological activity and directly participate at the end of the coagulation cascade to induce the formation of a fibrin clot at the site of bleeding. They include thrombin and combination products containing thrombin and certain passive hemostatic agents 92, 93 . All have a rapid onset of action and provide hemostasis within ten minutes in most patients 91 . As these agents are directly involved in the final physiological events of the coagulation cascade and bypass the initial enzymatic steps, their hemostatic action is less susceptible to coagulopathies caused by clotting-factor deficiencies or platelet dysfunction.
Although topical hemostatic agents are effective in stopping bleeding and reducing blood loss, they have potential disadvantages 92 . The expansion of a passive topical hemostatic agent can result in complications, such as the compression of nerves in surrounding tissue against bone or hard tissue with neurological consequences. Any residual product at the site may also potentiate a foreign-body reaction, chronic inflammation, or infection. We recommend that only the minimum amount of hemostatic agent necessary to achieve hemostasis be used and that as much of the agent as possible be removed once hemostasis has been achieved.
Minimally Invasive Spine Surgery
Intraoperative blood loss can be minimized by the use of less invasive operative approaches, such as paraspinal muscle-splitting, endoscopic, and percutaneous instrumentation techniques. In contrast to midline subperiosteal dissection and muscle retraction to gain access to the spinal canal, micro-endoscopic lumbar discectomy, with a direct approach to the herniated disc fragment under intraoperative fluoroscopic guidance and a musclesplitting technique, has been shown to produce a smaller surgical wound, less postoperative wound pain, and less intraoperative blood loss. Huang et al. 94 and Ryang et al. 95 demonstrated that lumbar discectomies performed with a micro-endoscopic technique are associated with a 50% reduction in intraoperative blood loss compared with that associated with standard open discectomies. Lumbar spine fusion can also be performed with minimally invasive techniques. These include a paraspinal musclesplitting approach and performance of percutaneous instrumentation under fluoroscopic control. Compared with conventional open procedures, which involve wide posterior exposure from the midline to the tips of the transverse processes and freehand application of instrumentation, minimally invasive techniques can markedly reduce intraoperative blood loss. Rodríguez-Vela et al. Minimally invasive techniques are not without disadvantages. With the endoscopic approach, operative dissection is performed via a two-dimensional, small visual field. Perceptions of anatomy and depth are more difficult compared with those with open procedures. Furthermore, minimally invasive techniques frequently require special long instruments that are passed through the working portals to gain access to the operative sites. All of these characteristics make minimally invasive surgery technically more demanding and may lead to higher surgical complication rates, especially in inexperienced hands. Nowitzke 100 reported his early experience with micro-endoscopic discectomy. He estimated that he needed to perform thirty procedures to learn the technique to perform the operation proficiently, and he encountered seven complications, including dural tears and wrong-level surgery.
Postoperative Period
Postoperative Red-Blood-Cell Salvage There have been few studies on postoperative blood salvage after spine surgery 20, 21, 101 . Because postoperative salvage was combined with other techniques in earlier studies, it was impossible to evaluate the effect of this technique. Sebastián et al. 101 evaluated 6, 2011 postoperative salvage only and found that it reduced the allogeneic blood requirement by 30%. Although the reinfusion of unwashed postoperatively collected blood has been criticized for introducing harmful substances such as cell debris, marrow fat, fibrin, and free hemoglobin, the use of standard 40-mm blood filters for infusion of recovered blood has solved this potential problem [102] [103] [104] . Unlike intraoperative salvage, postoperative salvage has not been evaluated in terms of its costeffectiveness.
General Considerations Indications for Transfusion
In recent years, there has been a general paradigm shift toward many surgeons and anesthesiologists adopting more restrictive indications for red blood-cell transfusion, although whether this has had any significant impact on the reduction of allogeneic blood usage remains controversial 105 . The proof-ofconcept Canadian Transfusion Requirements in Critical Care (TRICC) study 106 , which compared a more restrictive threshold for transfusion (a hemoglobin level of 7 g/dL) with a more liberal threshold (10 g/dL) showed no significant difference in overall mortality between the two groups. The same group of investigators found similar results in children 107 . A recent systematic review 108 showed that, in forty-two of forty-five studies, the risks of red blood-cell transfusion outweighed the benefits, the risk was neutral in two studies, and the benefits outweighed the risks in a subgroup (elderly patients with an acute myocardial infarction and a hematocrit of <30%) of a single study.
On the basis of the results of these studies and others, evidence-based practice guidelines and recommendation statements on red blood-cell transfusion were developed and have been constantly updated by relevant associations and societies. For instance, the Association of Anaesthetists of Great Britain and Ireland (AAGBI) stated that a hemoglobin concentration of <7 g/dL is a ''strong indication for [red-blood-cell] transfusion'' while transfusion is not required when the hemoglobin concentration is >10 g/dL 109 . Similarly, the American Society of Anesthesiologists Practice Guidelines recommended that ''red blood cells should usually be administered when the hemoglobin level is less than 6 g/dl'' and ''strongly agree that red blood cells are usually unnecessary when the level is more than 10 g/dl.'' 110 The determination of whether intermediate hemoglobin concentrations (i.e., 6 to 10 g/dL) justify or require red blood-cell transfusion should be based on the patient's risk for complications of inadequate oxygenation. Moreover, the indications for transfusion of autologous red blood cells may be more liberal than those for transfusion of allogeneic red blood cells because the former is associated with less frequent (although still important) risks.
Although the most desirable transfusion threshold for patients undergoing spine surgery has not been specifically studied, the more general guideline of performing a transfusion when the hemoglobin concentration is <7 g/dL and of carefully weighing the risks against the benefits when the hemoglobin concentration is between 7 and 10 g/dL should apply to most patients.
Use of Combination of Techniques
Many of the techniques and concepts discussed above can be conveniently combined in the perioperative period. However, although there have been small-scale studies in which more than one technique was employed 13, 19, 20 , whether such combinations are desirable has not been properly evaluated and remains unknown. Safety is the most important concern. For instance, the risk factors for postoperative loss of vision when an operation in performed with the patient in the prone position include both hypotension and hemodilution. Therefore, caution should be exercised before combining induced hypotension with a lower tolerance for transfusion. Even when the patient is not in the prone position, it is conceivable that the safety of these techniques individually may not be extrapolated to the situation when the techniques are combined, as tissue oxygen delivery is described by the equation: cardiac output · hemoglobin concentration · oxygen saturation. Similarly, as autologous predonation may lower preoperative hemoglobin concentration, the advantage of combining this technique with acute intraoperative hemodilution, or the advantage of one over the other, is currently unknown. The marginal benefit of combining different techniques, such as induced hypotension, hemostatic drugs, and intrathecal morphine, is also unknown. If it can be demonstrated that there is little marginal benefit in adding a technique that tends to be associated with more severe complications, such as induced hypotension, then this may indicate a change in current practice. We could not find any clinical studies that addressed these issues. Some of these techniques do seem synergistic when combined. For instance Waters et al. 111 , using mathematical models, showed that the combination of intraoperative red-blood-cell salvage and acute normovolemic hemodilution would allow more patients to avoid allogeneic blood transfusion than would use of one or the other individual technique alone.
Numerous techniques to reduce perioperative blood loss and allogeneic blood transfusion during major spine surgery have been investigated. In particular, many new studies have provided data since the review by Szpalski et al. 1 (see Appendix). The effectiveness of many techniques remains to be proven by large-scale randomized controlled trials. In particular, there is a paucity of studies evaluating the safety and marginal benefit of combining different techniques. Individually, intraoperative acute normovolemic hemodilution, use of tranexamic acid, use of intrathecal morphine, proper positioning, and modification of operative techniques seem most promising. On the other hand, additional studies are required to establish either the effectiveness or the safety of preoperative autologous predonation; mandatory discontinuation of use of antiplatelet agents; intraoperative and postoperative blood salvage; use of aprotinin, epsilonaminocaproic acid, recombinant factor VIIa, or desmopressin; induced hypotension; avoidance of hypothermia; and minimally invasive operative techniques. loss and allogeneic blood transfusion in patients undergoing major spine surgery is available with the online version of this article at jbjs.org. n
